Govt Job for Research Associate at Indian Institute of Technology

The Indian Institute of Technology Kanpur was established in the year 1960. The Parliament of India passed the ‘Institutes of Technology Act 1961’ declaring all the IITs as “Institutions of National Importance”.

The Parliamentary Act has given absolute autonomy to the IITs.

When the foundation stone of the IIT system was laid, it was perceived that taking help from the industrially advanced western countries might be lot more effective in achieving the status of a world class technical institute. Hence, IIT Kanpur had a massive collaboration with USA through a specially created programme- KIAP (Kanpur Indo American Programme).

Applications are invited for one post of Research Associate under the project entitled “Superabsorbent Hemostatic Sponges for Arterial Bleeding and Other Wound Types”

Minimum Qualification : PhD in Materials Science/Biological Science

Desirable Experience/Higher Qualification : Candidate with proven experience of working with biodegradable polymers and having hands on experience with processing and characterization of Superabsorbent Hemostatic sponges for arterial bleeding type projects will be given preference.

Candidates are expected to work in multidisciplinary research area. Proficiency in written and spoken English is mandatory.
Salary Range : 35000/- (Fixed) per month

The position is temporary for a maximum of one year or end of project whichever will be earlier.

Last Date for Application : Those interested must send their application on plain paper with resume, list of three references and copies of professional academic records (mark sheet/Certificate) to vverma@iitk.ac.in with cc to gpbajpai@iitk.ac.in latest by 08-02-2021. Hard copy application will not be entertain.

Related Posts

  • Pharma
  • July 22, 2025
  • 95 views
DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

  • Pharma
  • July 16, 2025
  • 486 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end